REGN
REGENERON PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$930.67
−4.39%Margins
Gross margin
85.8%
EBITDA margin
37.0%
EBIT margin
29.5%
Net margin
28.5%
FCF margin
21.2%
14.4%
Return on equity
10.8%
Return on assets
13.8%
Return on invested capital
0.39x
Asset turnover
$4.6B
Cash from operations
$90
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026